Breast Imaging Market 2020-2026
在預測期內，全球乳房成像市場預計將以 6.3% 的顯著複合年增長率增長。2019年市場規模達到37億美元，預計2026年將達到56億美元。乳房成像是再現乳房形狀的過程。幫助醫療專業人員識別乳房異常並使用成像技術進行診斷。在診斷程序中使用了各種乳房成像技術，例如乳房 X 線照相術、乳房斷層合成術、MRI、超聲和半乳造影術。由於多種因素，全球乳房成像市場正在以相當大的速度增長，包括乳腺癌發病率和患病率的增加以及全球老年人口的增加。
Global Breast Imaging Market Size, Share & Trends Analysis Report by Ionizing Breast Technologies (Analog Mammography, 3D Breast Tomosynthesis, Cone Beam Computed Tomography (CB-CT), Positron Emission Mammography (PEM), and Molecular Breast Imaging), By Non-Ionizing Breast Technologies (Breast MRI, Breast Ultrasound, Optical Imaging, and Breast Thermography), By Screening Method (Symptomatic Imaging and Asymptomatic Imaging), Forecast Period 2021-2027
The global breast imaging market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The market was valued at $3.7 billion in 2019 and is anticipated to reach $5.6 billion in 2026. Breast imaging is the process of reproduction of the breast's form. It supports medical professionals to identify breast abnormalities and diagnose them with imaging technologies. There are various breast imaging techniques used for the diagnostic procedure such as mammography, breast tomosynthesis, MRI, ultrasound, and galactography. The global breast imaging market is growing at a significant rate due to various factors such as increasing incidences and prevalence of breast cancer and the growing geriatric population across the globe. As per the WHO (World Health Organization), around 2.1 million cases were registered globally related to breast cancer in 2018 which is expected to reach more than 2.4 million cases in 2025. Asia-Pacific had the highest cases of breast cancer with 911,000 cases, whereas 522,000 and 262,000 cases were registered in Europe and North America, respectively, in 2018. The growth in breast cancer is significantly generating the demand for breast imaging across the globe.
In addition, increasing investment and funding in research and development activities of breast cancer diagnostics and government initiatives to raise awareness among the people to propel the growth of the market. For instance, as per the National Cancer Institute research, around $574.9 million were funded in research of breast cancer. Certain factors act as barriers to market growth such as the high cost of imaging systems, side effects related to imaging, strict government regulations, and lack of awareness among women about breast cancer in developing countries. However, emerging technologies for breast imaging, increasing demand for breast imaging from the Asia-Pacific region, improving healthcare infrastructure, and increasing spending on healthcare create future opportunities for the growth of the market.
The global breast imaging market is analyzed by segmenting the market into ionizing breast imaging technologies and non-ionizing breast imaging technologies. Based on ionizing breast imaging technologies, the market is further segmented into analog mammography, 3D breast tomosynthesis, cone beam computed tomography (CB-CT), positron emission mammography (PEM), and molecular breast imaging. Whereas, based on non-ionizing breast imaging technologies, the market is categorized into breast MRI, breast ultrasound, optical imaging, and breast thermography. Moreover, the market is also segmented based on the breast imaging method into symptomatic and asymptomatic imaging.
Global Breast Imaging Market Share by Ionizing Breast Technologies, 2020 (%)
Source: OMR Global
Analog Mammography holds a significant share in the Market
The analog mammography held the major share in 2020 and is also anticipated to grow during the forecast period. Analog Mammography uses low-dose radiation to deliver high-quality X-rays and is capable of detecting tissue variations as small as 1-2mm in size. The X-ray beams are captured on film cassettes, and the result is an image depicting the breast from various perspectives and is then hung on a viewing screen. The factors such as raising awareness and various programs on breast screening have been contributing to the rapid market growth. When opposed to unscreened populations, these screening systems have been found to save lives. For instance, the National Breast Cancer Screening Programme in the Netherland was created for people aged 50 to 75 years. Women in this age group are invited for mammography once every two years as part of the initiative. Similarly, as per Breast Screen Australia, women aged 50-74 in Australia are required to get free mammography every two years as part of the government's nationwide screening scheme.
The global breast imaging market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds a dominant position in the global breast imaging market, followed by Europe. The growth is mainly driven by the demand for such technology for the treatment of breast cancer, and the presence of developed technology and healthcare infrastructure. For instance, as per the American Cancer Society, in 2021, it an estimated that around 281,550 new cases of invasive breast cancer are expected to be diagnosed in women in the US. Apart from it, around 49,290 new cases of non-invasive breast cancer in the US. Europe covers noteworthy market share with high initiatives in the field of research & development and spreading awareness among people.
Global Breast Imaging Market Growth, by Region 2021-2027
Source: OMR Global
Asia-Pacific is projected to have a considerable share in the global breast imaging market
Asia-Pacific is anticipated to hold a considerable market share in the global breast imaging market during the forecast period. This is due to the increasing prevalence of breast cancer which is creating demand for imaging technologies. For instance, according to the Organization for Economic Cooperation and Development (OECD), in 2018, around 839,000 women were diagnosed with breast cancer, and 286,000 mortalities occurred in the Asia-Pacific region. Moreover, the increasing awareness related to breast cancer, rising government focus on disease diagnosis and treatment, and the increasing disposable income in emerging economies are some of the major factors for the growth of the market. Moreover, the developed economies such as Japan, Australia, and South Korea have a well-developed breast cancer diagnosis infrastructure with high disposable income & a high geriatric population base, driving the market growth.
Market Players Outlook
Several players are operating in the global breast imaging market. Hologic, Inc., Koninklijke Philips N.V., Canon Medical Systems Corp., Carestream Health, and Siemens Healthcare Ltd. are some of the major players operating in the global breast imaging market. These players focus on providing novel and technically advanced breast imaging solutions for different end-users such as hospitals and clinics to gain a considerable market share. Furthermore, mergers and acquisitions, partnerships, collaborations, and product launches are some crucial strategies that are being adopted by the market players to stay competitive. For instance, in May 2019, Bracco imaging S.P.A has acquired Blue Earth Diagnostics, a molecular imaging company for around $450 million. Blue Earth Diagnosis working as a subsidiary of Bracco Imaging.
The Report Covers
Market value data analysis of 2020 and forecast to 2027.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global breast imaging market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where in the market.